Replicate is a company that utilizes synthetic biology to create self-replicating RNAs (srRNAs) that can combat diseases. They focus on addressing drug resistance in cancers, developing treatments for autoimmune and inflammatory disorders, and other diseases. With their customizable srRNA platform and diverse vector repertoire, they aim to make srRNA therapeutics widely available for all patients.